Tickwind
HoyOportunidadesMercadosChat con IA
ES
Iniciar sesiónRegistrarse
Tickwind

Lee cada tick. Ve hacia dónde sopla el mercado.

  • XInglés
  • TelegramChino
  • BoletínInglés

Producto

  • Mercados
  • Zonas temáticas
  • Todas las acciones
  • Comparar
  • Acciones en tendencia
  • Oportunidades
  • Noticias
  • Discusión
  • Lista de seguimiento
  • Novedades

Cuenta

  • Ajustes
  • Boletín
  • Para prensa e investigación
  • Servidor MCP
  • Contacto
  • Iniciar sesión
  • Registrarse
MercadosZonas temáticasTodas las accionesCompararAcciones en tendenciaOportunidadesNoticiasDiscusiónLista de seguimientoNovedadesAjustesBoletínPara prensa e investigaciónServidor MCPContactoIniciar sesiónRegistrarse

© 2026 Tickwind. No es asesoría de inversión.

Hecho para el inversor curioso.

Home/BKHAU/vs peers

BKHAUBlack Hawk Acquisition Corpvs its industry peers

A metric-by-metric comparison of Black Hawk Acquisition Corp against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.

Full peer comparison
Peers: same SEC industry
EmpresaMarket capP/E (TTM)P/BP/SRevenue growth (YoY)Earnings growth (YoY)EBIT marginROEROICPiotroski F1y total returnDividend yield
BKHAUBlack Hawk Acquisition CorpEsta$54M#8————-30.6%#11————136.5%#194.1%#1
TNYATenaya Therapeutics, Inc.$84M#1—1.2x#8——18.5%#4—-130.5%#10——-73.7%#11—
VXRTVaxart, Inc.$80M#22.0x#11.0x#50.3x#1726.7%#1124.4%#17.6%#10.0%#122.5%#1—-24.0%#5—
CSBRCHAMPIONS ONCOLOGY, INC.$68M#3—17.5x#121.1x#24.4%#3-125.0%#15-1.9%#2-0.0%#2——-27.6%#6—
CRDFCardiff Oncology, Inc.$66M#4—2.5x#11112.0x#6-13.2%#4-0.9%#7-8256.3%#6-0.2%#3——-63.0%#10—
CGTXCOGNITION THERAPEUTICS INC$65M#5—2.0x#10——30.9%#3—-71.1%#8——-58.5%#7—
GRMLWGreenland Mines Ltd$57M#6—1.0x#6——-71.6%#12—-18.2%#5-14.6%#2—105.7%#2—
INKTMiNK Therapeutics, Inc.$55M#7————-15.9%#9————-23.4%#4—
ELOXEloxx Pharmaceuticals, Inc.$53M#93.7x#21.1x#7—-100.0%#6-90.7%#13—-12.9%#4————
CRBUCaribou Biosciences, Inc.$48M#10—0.5x#34.3x#411.7%#20.7%#6-1329.4%#4-151.0%#11——-81.7%#13—
KLRSKalaris Therapeutics, Inc.$48M#11—0.8x#4288.5x#7—37.2%#2-27970.9%#7-75.3%#9——-59.9%#8—
LONALeonaBio, Inc.$47M#12—1.4x#9——-9.3%#8—-315.5%#12——23.8%#3—
TILInstil Bio, Inc.$47M#13—0.4x#2—-100.0%#63.7%#5—-66.5%#7——-60.7%#9—
IMAImageneBio, Inc.$47M#14—0.3x#158.2x#5-77.1%#5-24.0%#10-6056.4%#5-31.9%#6————
PTHS$42M#15——2.5x#3—-444.6%#16-193.1%#3—————
TVGNTevogen Bio Holdings Inc.$41M#16————-91.4%#14————-79.7%#12—

Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-04.

Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice

BKHAU's peers

TNYAVXRTCSBRCRDFCGTXGRMLWINKTELOXCRBUKLRSLONATILIMAPTHSTVGN
← BKHAU overview